GENE ONLINE|News &
Opinion
Blog

2025-12-01|

Researchers Develop Shape-Morphable Origami Waveguides for Real-Time Electromagnetic Wave Control

by GOAI
Share To

Researchers have introduced a new class of shape-morphable origami electromagnetic waveguides, combining principles of origami with advanced electromagnetic engineering. These structures can dynamically alter their geometry, allowing for adaptable control over the propagation of electromagnetic waves. The development represents a significant advancement in the field of wave management and could potentially lead to new applications in communications, sensing, and other technologies reliant on precise wave manipulation.

The design integrates the folding techniques of origami with materials engineered to guide electromagnetic waves. By adjusting the shape of these waveguides, researchers demonstrated the ability to modify how waves travel through them in real time. This approach enables greater flexibility compared to traditional static waveguides, which are limited by fixed geometries. The findings highlight how ancient design concepts can intersect with modern technology to address complex challenges in science and engineering.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: December 1, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top